1. Home
  2. ESNT vs PTCT Comparison

ESNT vs PTCT Comparison

Compare ESNT & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essent Group Ltd.

ESNT

Essent Group Ltd.

SELL

Current Price

$64.57

Market Cap

5.8B

Sector

Finance

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$59.31

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ESNT
PTCT
Founded
2008
1998
Country
Bermuda
United States
Employees
518
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.5B
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
ESNT
PTCT
Price
$64.57
$59.31
Analyst Decision
Buy
Buy
Analyst Count
8
15
Target Price
$74.00
★ $100.33
AVG Volume (30 Days)
776.9K
★ 1.2M
Earning Date
11-06-2026
10-29-2026
Dividend Yield
★ 2.20%
N/A
EPS Growth
0.73
★ 264.48
EPS
★ 3.89
0.90
Revenue
★ $1,260,935,000.00
$264,734,000.00
Revenue This Year
$8.00
N/A
Revenue Next Year
$4.64
$9.47
P/E Ratio
★ $16.40
$67.73
Revenue Growth
1.45
★ 36.19
52 Week Low
$55.34
$58.80
52 Week High
$70.37
$90.87

Technical Indicators

Market Signals
Indicator
ESNT
PTCT
Relative Strength Index (RSI) 52.92 34.70
Support Level $63.90 N/A
Resistance Level $66.91 $68.93
Average True Range (ATR) 1.57 1.93
MACD 0.44 -0.15
Stochastic Oscillator 95.83 13.82

Price Performance

Historical Comparison
ESNT
PTCT

About ESNT Essent Group Ltd.

Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: